Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells
- 31 January 2012
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 33 (2), 565-582
- https://doi.org/10.1016/j.biomaterials.2011.09.055
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Cationic amphiphilic polyproline helix P11LRR targets intracellular mitochondriaJournal of Controlled Release, 2010
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong RemissionCancer Research, 2009
- Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosisToxicology, 2009
- Breast cancer stem cells: implications for therapy of breast cancerBreast Cancer Research, 2008
- Enhanced therapeutic effects on the multi‐drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrineFundamental & Clinical Pharmacology, 2008
- A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomesJournal of Controlled Release, 2008
- Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targetsExperimental Cell Research, 2008
- Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cellsBreast Cancer Research, 2008
- Profiling cancer stem cells using protein array technologyEuropean Journal of Cancer, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005